Adalimumab (20mg)
Exemptia 20 mg/0.4ml Injection is used in the treatment of ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis and Crohn’s disease.
1 ml in 1 prefilled syringe
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Exemptia 20 mg/0.4ml Injection blocks the action of certain chemical messengers that are responsible for inflammation, swelling and redness associated with certain joint diseases.
Related Warnings
Interaction with alcohol is unknown. Please consult your doctor.
Exemptia 20 mg/0.4ml Injection is probably safe to use during pregnancy.
Animal studies have shown low or no adverse effect on the foetus, however, there are limited human studies. Please consult your doctor.
Exemptia 20 mg/0.4ml Injection is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.
Do not drive unless you are feeling well.
Exemptia 20 mg/0.4ml Injection may cause room spinning sensation and vision disturbances. This may affect your driving ability.
There is limited information available on the use of Exemptia 20 mg/0.4ml Injection in patients with kidney disease. Please consult your doctor.
There is limited information available on the use of Exemptia 20 mg/0.4ml Injection in patients with liver disease. Please consult your doctor.
